SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Mike who wrote (1417)2/26/2003 6:15:04 PM
From: Sergio H  Read Replies (1) | Respond to of 23958
 
Mike, I agree with your enthusiasm on MDCO. New guidance from co. makes it easier to set a price target. Projected rev growth of 60% with earnings of .69/share = a forward P.E. of 27 = a PEG of .50. It's early in the game, and they've proven that Angiomax launch is a success. With continued growth for the following year at just half of the projected rate for the coming year, MDCO should be in the 40 price range.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News